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Appraisal Clinical Practice Guidelines
Date of latest update: June 2005. Date of next update: Not 
given. Patient group: Adults (aged > 18 years) with chronic 
non-specific low back pain. Intended audience: Individuals 
or groups developing or updating practice guidelines, 
professional associations, health care providers, health 
promotion agencies, industry/employers, educationalists, 
policymakers, people with low back pain, and the 
general public. Additional versions: Nil to date. Expert 
working group: Eleven European professionals from nine 
countries, experts in the field of low back pain research 
from disciplines including anaesthesiology, psychology, 
physiology, rehabilitation medicine, physical medicine, 
physiotherapy, general practice, epidemiology, and 
orthopaedic surgery. Funded by: European Commission, 
Research Directorate-General, Department of Policy, Co-
ordination and Strategy. Consultation with: Feedback was 
received from an additional 15 professionals representing a 
variety of disciplines from 12 European countries who were 
in the COST B13 Management Committee. COST is an 
intergovernmental framework for European Co-operation in 
the field of Scientific and Technical Research, allowing the 
co-ordination of nationally funded research on a European 
level. Approved by: Not documented specifically. Location: 
This publication can be accessed via the PEDro database, 
or directly at: http://www.backpaineurope.org/web/files/
WG2_Guidelines.pdf 
Chronic non-specific low back pain
Description: 207 page document with recommendations 
based on 675 studies. The guidelines include a summary, 
methods, definitions and epidemiology, evidence for patient 
assessment to diagnose and prognose chronic non-specific 
low back pain, and evidence for the efficacy of interventions. 
Types of patient assessment reviewed include evidence 
for diagnostic triage, case history, physical examination, 
imaging, and electromyography. Interventions reviewed 
for evidence of effect include physical treatments (eg, 
electrotherapy, lumbar supports, traction), exercise therapy, 
manual therapy (mobilisation/manipulation and massage), 
back schools and education, cognitive-behavioural therapy, 
multidisciplinary treatment, pharmacological procedures 
(eg, NSAIDs, muscle relaxants) and invasive procedures 
(eg, acupuncture, injections and nerve blocks, denervation 
procedures). A key section for physiotherapists is the 
summary (pp. 11–25), which contains a summary of the 
level of evidence available for each topic, concluding with 
recommendations. Four levels of evidence for treatment 
are provided throughout the document. Recommendations 
for each treatment were then given based on the strength 
of evidence for its effectiveness in combination with other 
known concerns such as cost effectiveness, safety, side 
effects and general provisos regarding the evidence itself 
(eg, duration of effect). These categories: ‘recommend, 
‘consider using’, ‘we cannot recommend’, and ‘we do not 
recommend’ are outlined in detail on p 28.
Sandra Brauer
The University of Queensland
Date of latest update: January, 2006.  Date of next update: 
Not given. Patient group: Patients with impaired airway 
clearance. Intended audience: Physicians. Additional 
versions: Nil to date. Expert working group: An international 
panel of 26 experts representing 7 clinical specialties 
formulated recommendations. Systematic reviews of 
evidence were performed by the Centre for Clinical Health 
Policy Research, Duke University Medical Centre. Funded 
by: American College of Chest Physicians. Consultation 
with: The American College of Chest Physicians, American 
College of Physicians, Canadian Thoracic Society, and 
American Thoracic Society. Approved by: American 
Thoracic Society and Canadian Thoracic Society. Location: 
McCool FD, Rosen MJ (2006) Nonpharmacologic airway 
clearance therapies: ACCP evidence-based clinical practice 
guidelines. Chest 129 (1 Suppl): 250S–259S. 
Nonpharmacologic airway clearance therapies
Description: 10 page document. Ten major recommendations 
were formed from 69 articles and are summarised on page 
257S. Treatment/management practices reviewed include 
chest physiotherapy (percussion, postural drainage, and 
vibration), manually assisted cough, forced expiratory 
technique (huffing), autogenic drainage, respiratory muscle 
training, positive expiratory pressure, devices designed to 
oscillate gas in the airway and mechanical cough assistive 
devices. The major outcomes considered in the effectiveness 
of these interventions included sputum characteristics, 
forced expiratory volume in one second, coughing efficacy, 
and incidence of respiratory complications. Quality of the 
evidence was rated in 4 categories. Evidence was rated 
‘good’ if based on good RCTs or meta-analyses, ‘fair’ if 
based on other controlled trials or RCTs with minor flaws, 
‘low’ if evidence was based on non-randomised, case-
control or other observational studies, or ‘expert opinion’ 
if based on the consensus of panel experts in the topic 
field. Recommendations were graded by consensus of the 
panel, using the ACCP Health and Science Policy Grading 
System, based on the quality of evidence and net benefits of 
the intervention. Detailed criteria of this grading system are 
not in this document, but can be found in a summary of this 
guideline at the National Guideline Clearinghouse website: 
http://www.guideline.gov/summary/summary.aspx?doc_id
=8676&nbr=004841&string=airway+AND+clearance
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